HLTH vs. RPID, AXDX, OMIC, TLIS, ASTC, PRPO, TBIO, HTGMQ, VMD, and TLMD
Should you be buying Cue Health stock or one of its competitors? The main competitors of Cue Health include Rapid Micro Biosystems (RPID), Accelerate Diagnostics (AXDX), Singular Genomics Systems (OMIC), Talis Biomedical (TLIS), Astrotech (ASTC), Precipio (PRPO), Telesis Bio (TBIO), HTG Molecular Diagnostics (HTGMQ), Viemed Healthcare (VMD), and SOC Telemed (TLMD).
Cue Health (NASDAQ:HLTH) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.
Rapid Micro Biosystems has lower revenue, but higher earnings than Cue Health. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Cue Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Cue Health had 3 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 5 mentions for Cue Health and 2 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 1.44 beat Cue Health's score of 0.43 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.
Cue Health has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.
Rapid Micro Biosystems received 3 more outperform votes than Cue Health when rated by MarketBeat users. Likewise, 26.67% of users gave Rapid Micro Biosystems an outperform vote while only 7.14% of users gave Cue Health an outperform vote.
45.5% of Cue Health shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 12.5% of Cue Health shares are owned by company insiders. Comparatively, 30.4% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Rapid Micro Biosystems has a net margin of -224.73% compared to Cue Health's net margin of -526.48%. Rapid Micro Biosystems' return on equity of -42.25% beat Cue Health's return on equity.
Summary
Rapid Micro Biosystems beats Cue Health on 11 of the 15 factors compared between the two stocks.
Get Cue Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for HLTH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HLTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cue Health Competitors List
Related Companies and Tools
